Study of the effect of drug composition erythropoietin, pentoxifylline and vitamin D3 on the consciousness level of patients with brain injury

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130812014333N157

Enrollment

Registered

2020-12-22

Start date

2021-01-04

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain damage. Unspecified brain damage due to birth injury

Interventions

Intervention 1: The intervention group will be treated with 2000 units of erythropoietin, pentoxifylline vitamin D3 (in 6 sessions with an interval of 2 days for two weeks)in addition to routine treat

Eligibility

Sex/Gender

All

Age

16 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age over 16 and under 65 years Admission before 24 hours of brain injury No spinal cord injury Patients with severe and moderate brain injury admitted to the intensive care unit

Exclusion criteria

Exclusion criteria: History of pulmonary embolism or deep vein thrombosis DVT Any malignancy and cancer treatment with Erythropoietin in the last 30 days Pregnancy Uncontrolled hypertension (systolic above 200 or diastole above 110 mm Hg) Heart attack in the past year History of epilepsy

Design outcomes

Primary

Measure	Time frame
Level of consciousness. Timepoint: daily to clearance time. Method of measurement: Glasgow coma scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ali Akrami

Kermanshah University of Medical Sciences

akramiali7@gmail.com+98 83 3427 4618

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026